Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2021-10-01 Acc 0001209191-21-058530

Director bought 2,982 shares at an average $2.83 ($8,436)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Galante Joseph C Director	2021-09-01	Purchase	+142	$2.88	$409	37,955	D
Galante Joseph C Director	2021-09-02	Purchase	+142	$2.88	$409	38,097	D
Galante Joseph C Director	2021-09-03	Purchase	+142	$2.85	$405	38,239	D
Galante Joseph C Director	2021-09-07	Purchase	+142	$2.79	$396	38,381	D
Galante Joseph C Director	2021-09-08	Purchase	+142	$2.89	$410	38,523	D
Galante Joseph C Director	2021-09-09	Purchase	+142	$2.77	$393	38,665	D
Galante Joseph C Director	2021-09-10	Purchase	+142	$2.78	$395	38,807	D
Galante Joseph C Director	2021-09-13	Purchase	+142	$2.96	$420	38,949	D
Galante Joseph C Director	2021-09-14	Purchase	+142	$3.02	$429	39,091	D
Galante Joseph C Director	2021-09-15	Purchase	+142	$2.86	$406	39,233	D
Galante Joseph C Director	2021-09-16	Purchase	+142	$2.91	$413	39,375	D
Galante Joseph C Director	2021-09-17	Purchase	+142	$2.85	$405	39,517	D
Galante Joseph C Director	2021-09-20	Purchase	+142	$2.82	$400	39,659	D
Galante Joseph C Director	2021-09-21	Purchase	+142	$2.81	$399	39,801	D
Galante Joseph C Director	2021-09-22	Purchase	+142	$2.76	$392	39,943	D
Galante Joseph C Director	2021-09-23	Purchase	+142	$2.75	$391	40,085	D
Galante Joseph C Director	2021-09-24	Purchase	+142	$2.74	$389	40,227	D
Galante Joseph C Director	2021-09-27	Purchase	+142	$2.79	$396	40,369	D
Galante Joseph C Director	2021-09-28	Purchase	+142	$2.76	$392	40,511	D
Galante Joseph C Director	2021-09-29	Purchase	+142	$2.82	$400	40,653	D
Galante Joseph C Director	2021-09-30	Purchase	+142	$2.72	$386	40,795	D
Open-market purchases · 2,982 sh · avg $2.83 · $8,436